P1633: OUTCOME OF SURGICAL INTERVENTIONS IN PATIENTS WITH HAEMOPHILIA A AND B TREATED WITH EXTENDED HALF-LIFE (EHL) FACTOR CONCENTRATES IN A SINGLE CENTRE

• Ines Vaide,
• Saskia Gottstein,
• Cornelia Kubicek,
• Maria Orlovich,
• Robert Klamroth

Affiliations

Ines Vaide

1 University of Tartu. Institute of Clinical Medicine, Department of Hematology and Oncology, Tartu, Estonia

Saskia Gottstein

3 Vivantes Clinic in Friedrichshain, Innere Medicin- Angiologie und Hämostaseologie, Berlin, Germany

Cornelia Kubicek

3 Vivantes Clinic in Friedrichshain, Innere Medicin- Angiologie und Hämostaseologie, Berlin, Germany

Maria Orlovich

3 Vivantes Clinic in Friedrichshain, Innere Medicin- Angiologie und Hämostaseologie, Berlin, Germany

Robert Klamroth

3 Vivantes Clinic in Friedrichshain, Innere Medicin- Angiologie und Hämostaseologie, Berlin, Germany